Oncosoft | Top AI Driven Radiation Therapy Solution in APAC 2025

MedTech Outlook Magazine

Oncosoft
The Unified Platform for Streamlined Radiation Oncology Workflows

Jin Sung Kim, Oncosoft | Medical Tech Outlook | Top AI Driven Radiation Therapy Solution in APACJin Sung Kim, CEO
Radiation therapy has never been short on innovation. Scanners capture tumors in remarkable detail, contouring software outlines them with precision, planning tools adapt dosing strategies in real time, and delivery systems deliver radiation with pinpoint accuracy.

Each advance has raised the standard of care. But because these tools are often built in silos by different vendors, they rarely speak the same language. Data sits in separate systems, records are transferred manually and the very breakthroughs designed to speed care can create friction where time matters most.

Oncosoft, a vendor-neutral platform, resolves this disconnect with an ecosystem designed to unify the entire radiation therapy workflow, from diagnosis through follow-up. In addition to the core modules OncoStudio and OncoFlow, Oncosoft is expanding its treatment stages through the in-development OncoRPT and OncoPlan modules. Slated to be coordinated through Oncosoft’s central AI engine, OncoAgent, this system will automate the complex, repetitive tasks that once consumed hours of clinical effort and ensure information flows securely and continuously across departments.



More than 100 hospitals worldwide have already adopted Oncosoft. For them, the value is clear. Oncosoft doesn’t demand a costly rip-and-replace of existing infrastructure. Instead, the vendor-neutral platform is designed for flexible integration with existing Picture Archiving and Communication Systems (PACS), Treatment Planning Systems (TPS), Electronic Medical Records (EMR) and therapy machines by adhering to international standards such as DICOM and HL7. Avoiding vendor lock-in protects past investments, lowers adoption barriers and gives healthcare institutions the freedom to scale on their own terms.

“We’re building a solution that benefits the entire healthcare ecosystem,” says Jin Sung Kim, CEO. “Clinicians can focus on what matters most—patient care—instead of inefficient, time-consuming tasks. Hospitals achieve better resource utilization and workflow integration. Most importantly, patients receive faster, more personalized treatment with reduced side effects. It’s about creating better outcomes for everyone.”

Streamlining Every Stage of Cancer Care

Every stage of radiation therapy has its own pressure point, whether it’s contouring tumors, coordinating workflows or preparing for advanced therapies.
The most time-consuming stage has always been contouring. Outlining tumors and organs by hand can take hours, sometimes days. OncoStudio reduces that to minutes. Its AI-driven auto-contouring achieves over 90 percent accuracy for organs at risk (OAR), shortening planning cycles and giving patients faster access to treatment. And with FDA 510(k) clearance and Japanese medical device certification, hospitals gain assurance that speed comes with proven safety and compliance. From there, the challenge shifts from defining treatment to delivering it. OncoFlow connects the dots. Acting as the central nervous system of radiation therapy, it unifies data and workflows across departments in real time. The result is less manual burden, fewer errors and a smoother patient journey from imaging to delivery.

  • We're building a solution that benefits the entire healthcare ecosystem. Clinicians can focus on what matters most—patient care—instead of inefficient, time-consuming tasks. Hospitals achieve better resource utilization and workflow integration. Most importantly, patients receive faster, more personalized treatment with reduced side effects. It's about creating better outcomes for everyone.


Oncosoft also equips hospitals for what’s next with a roadmap that includes OncoRPT for precision dosimetry in radiopharmaceutical therapy and OncoPlan for applying intelligence to particle therapy, a rapidly expanding frontier. These next-generation solutions will allow hospitals to advance beyond today’s standards and lead in highly personalized cancer care.

Trusted Partnerships Driving Global Impact

When the Mayo Clinic adopts 10 units for OncoStudio and OncoFlow, the industry takes notice. It demonstrates that even the most advanced oncology centers see tangible value in Oncosoft’s ability to bring operational harmony across departments and improve patient well-being at scale.

Severance Hospital has validated Oncosoft clinically for six years straight. That kind of longitudinal validation is rare in radiation oncology. It signals more than technical performance. It proves reliability, safety and trust in real-world settings where accuracy and patient outcomes are scrutinized daily.

A subscription-based pricing model makes this level of innovation accessible. Instead of forcing hospitals into heavy upfront capital investments, Oncosoft lowers adoption barriers through predictable, subscription-based pricing. This makes advanced radiation oncology tools scalable and attainable for institutions otherwise locked out of next-generation technology.

Taken together, these milestones position Oncosoft not just as a software company but as a leader shaping the future of radiation oncology. By unifying fragmented systems into one coordinated pathway of care, it is helping hospitals worldwide deliver cancer treatment that is faster, safer, more consistent and ultimately more humane.

AI Driven Radiation Therapy Solutions Info

Q1

How does Oncosoft contribute to advancements in radiation therapy technology?

Oncosoft focuses on improving treatment planning and clinical decision support through AI-driven radiation therapy solutions tailored for oncology environments. Its technology is designed to help healthcare professionals manage complex radiation treatment workflows with greater efficiency and analytical support. By combining artificial intelligence with radiation therapy processes, the company supports more informed treatment planning while helping clinicians navigate large volumes of patient and treatment data more effectively.

Q2

What differentiates Oncosoft in the AI-driven radiation therapy solutions market?

A strong emphasis on data interpretation and clinical usability distinguishes Oncosoft within the AI-driven radiation therapy solutions space. The company develops tools intended to support healthcare professionals in evaluating treatment pathways, reviewing historical treatment information and identifying clinically relevant insights. Instead of replacing clinician expertise, its technology is designed to enhance decision-making capabilities and support more personalized radiation therapy planning strategies.

Q3

How do Oncosoft’s solutions support healthcare professionals?

Clinical teams managing oncology treatment programs often require systems capable of simplifying information analysis and supporting workflow efficiency. Oncosoft addresses these needs through AI-driven radiation therapy solutions that assist with data organization, treatment evaluation and clinical insight generation. Its platforms are designed to help healthcare professionals access relevant information more efficiently while supporting collaboration and consistency within radiation oncology operations.

Q4

Why is artificial intelligence important in radiation therapy planning?

Radiation therapy planning involves evaluating complex clinical variables, treatment histories and patient-specific considerations. Oncosoft applies AI-driven radiation therapy solutions to help healthcare providers process and interpret this information more effectively. Artificial intelligence enables the company’s technology to support pattern recognition, treatment assessment and data-driven recommendations, helping clinicians strengthen planning accuracy and operational efficiency within oncology care environments.

Q5

What role does innovation play in Oncosoft’s development strategy?

Innovation at Oncosoft centers on improving how radiation oncology teams interact with clinical data and treatment planning systems. Its AI-driven radiation therapy solutions are developed to align advanced analytics with practical healthcare applications. The company continues refining its technologies to support evolving oncology requirements while maintaining a focus on usability, workflow integration and clinically meaningful insight generation.

Q6

Why is Oncosoft recognized among top AI-driven radiation therapy solution companies?

Oncosoft has gained recognition through its focus on combining artificial intelligence with radiation oncology decision support. Its AI-driven radiation therapy solutions address growing industry demand for technologies that improve treatment planning efficiency and clinical insight accessibility. By concentrating on oncology-specific analytical capabilities and healthcare workflow support, the company has established itself as a relevant contributor within the evolving radiation therapy technology landscape.

Top AI Driven Radiation Therapy Solution in APAC 2025

Company
Oncosoft

Management
Jin Sung Kim, CEO

Description
Oncosoft delivers AI-powered software that accelerates radiation oncology workflows, automating treatment site detection and organ contouring. Its flagship OncoStudio and OncoFlow solutions enhance precision and compatibility, adhering to global imaging standards for seamless integration in clinical environments.